{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:40:29Z","timestamp":1790052029753,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DeBusk College of Osteopathic Medicine, Lincoln Memorial University"},{"name":"Southwestern Behavioral Healthcare, Inc."}],"content-domain":{"domain":["schres-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.schres.2014.11.032","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T10:31:45Z","timestamp":1418380305000},"page":"506-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia"],"prefix":"10.1016","volume":"161","author":[{"given":"Paul L.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Unfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willard","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Phillipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2014.11.032_bb0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.exer.2009.07.008","article-title":"Red blood cell plasmalogens and docosahexaenoic acid are independently reduced in primary open-angle glaucoma","volume":"89","author":"Acar","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s004060070004","article-title":"The epidemiology of onset and course of schizophrenia","volume":"250","author":"an der Heiden","year":"2000","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2014.11.032_bb0015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/B978-0-444-59565-2.00028-9","article-title":"Peroxisomal disorders","volume":"113","author":"Aubourg","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.schres.2014.11.032_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0167-4943(01)00105-4","article-title":"Plasmalogen levels in serum from patients with impaired carbohydrate or lipid metabolism and in elderly subjects with normal metabolic values","volume":"32","author":"Brosche","year":"2001","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.schres.2014.11.032_bb0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0167-4943(89)90049-6","article-title":"Erythrocyte membrane changes associated with nutrition and aging\u2014the role of plasmalogens","volume":"9","author":"Brosche","year":"1989","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.schres.2014.11.032_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000046315","article-title":"Decreased concentrations of serum phospholipid plasmalogens indicate oxidative burden of uraemic patients undergoing haemodialysis","volume":"90","author":"Brosche","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.schres.2014.11.032_bb0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1515\/CCLM.2007.111","article-title":"Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias","volume":"45","author":"Brosche","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.schres.2014.11.032_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.archger.2013.02.007","article-title":"Reduced plasmalogen concentration as a surrogate marker of oxidative stress in elderly septic patients","volume":"57","author":"Brosche","year":"2013","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.schres.2014.11.032_bb0045","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1515\/CCLM.2009.205","article-title":"Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease","volume":"47","author":"Dragonas","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.schres.2014.11.032_bb0050","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1073\/pnas.86.10.3479","article-title":"Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation","volume":"86","author":"Ford","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2014.11.032_bb0055","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1194\/jlr.P700023-JLR200","article-title":"Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia","volume":"48","author":"Goodenowe","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0920-9964(01)00245-6","article-title":"Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-interventions in schizophrenia","volume":"51","author":"Gottesman","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0065","doi-asserted-by":"crossref","first-page":"e6261","DOI":"10.1371\/journal.pone.0006261","article-title":"Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients","volume":"4","author":"Graessler","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.schres.2014.11.032_bb0070","first-page":"319","article-title":"Serum plasmalogens in ischemic cerebrovascular disease","volume":"20","author":"Hoerrmann","year":"1991","journal-title":"Vasa"},{"key":"10.1016\/j.schres.2014.11.032_bb0075","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1172\/JCI38832","article-title":"Disruptive insights in psychiatry: transforming a clinical discipline","volume":"119","author":"Insel","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.schres.2014.11.032_bb0080","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4002000","article-title":"Metabolomic mapping of atypical antipsychotic effects in schizophrenia","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2014.11.032_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.psychres.2012.02.019","article-title":"Impaired plasmalogens in patients with schizophrenia","volume":"198","author":"Kaddurah-Daouk","year":"2012","journal-title":"Psychiatry. Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2007.09.036","article-title":"Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients","volume":"98","author":"Kale","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0095","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI37335","article-title":"Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies","volume":"119","author":"Lewis","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.schres.2014.11.032_bb0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5551\/jat.14.12","article-title":"Plasmalogens in human serum positively correlate with high-density lipoprotein and decrease with aging","volume":"14","author":"Maeba","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.schres.2014.11.032_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0253-7176.119471","article-title":"Metabolic syndrome in schizophrenia","volume":"35","author":"Malhotra","year":"2013","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.schres.2014.11.032_bb0110","article-title":"Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial","author":"McFarlane","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2014.11.032_bb0115","doi-asserted-by":"crossref","first-page":"796462","DOI":"10.1155\/2013\/796462","article-title":"Adult medication-free schizophrenic patients exhibit long-chain omega-3 fatty acid deficiency: implications for cardiovascular disease risk","volume":"2013","author":"McNamara","year":"2013","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.schres.2014.11.032_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.prostaglandins.2009.09.005","article-title":"Docosahexaenoic acid neurolipidomics","volume":"91","author":"Niemoller","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.schres.2014.11.032_bb0125","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1194\/jlr.P045591","article-title":"Serum choline plasmalogens, particularly those with oleic acid in sn-2, are associated with proatherogenic state","volume":"55","author":"Nishimukai","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0130","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.pneurobio.2011.05.006","article-title":"Discovery and development of integrative biological markers for schizophrenia","volume":"95","author":"Oertel-Kn\u00f6chel","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.schres.2014.11.032_bb0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000341603","article-title":"Changes in phospholipid composition of erythrocyte membrane in Alzheimer's disease","volume":"2","author":"Oma","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"10.1016\/j.schres.2014.11.032_bb0140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2014.11.032_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/jms.2031","article-title":"Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes","volume":"47","author":"Schuhmann","year":"2012","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.schres.2014.11.032_bb0150","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/ndt\/13.10.2594","article-title":"A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients","volume":"13","author":"Stenvinkel","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.schres.2014.11.032_bb0155","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/ndt\/gfh035","article-title":"Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy","volume":"19","author":"Stenvinkel","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.schres.2014.11.032_bb0160","doi-asserted-by":"crossref","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2014.11.032_bb0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2012.08.014","article-title":"A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia","volume":"141","author":"van der Kemp","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0170","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/alzrt103","article-title":"Lipidomics of Alzheimer's disease: current status","volume":"4","author":"Wood","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.schres.2014.11.032_bb0185","first-page":"3","article-title":"Lipidomics analysis of postmortem interval: preliminary evaluation of human skeletal muscle","volume":"3","author":"Wood","year":"2013","journal-title":"Metabolomics"},{"key":"10.1016\/j.schres.2014.11.032_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1503\/jpn.090059","article-title":"Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients","volume":"35","author":"Wood","year":"2010","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2014.11.032_bb0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.schres.2014.08.029","article-title":"Lipidomics reveals dysfunctional glycosynapses in schizophrenia and the G72 transgenic mouse","volume":"159","author":"Wood","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2014.11.032_bb0195","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/schbul\/sbp027","article-title":"Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study","volume":"35","author":"Woods","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2014.11.032_bb0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5650\/jos.ess13226","article-title":"The proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome","volume":"63","author":"Yamazaki","year":"2014","journal-title":"J. Oleo Sci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996414007099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996414007099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T02:20:06Z","timestamp":1538014806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996414007099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":40,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0920996414007099"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2014.11.032","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2014.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}